001540 — AHN-GOOK PHARMACEUTICAL Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapContrarian

Annual cashflow statement for AHN-GOOK PHARMACEUTICAL Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	—	—	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-1,388	3,744	6,879	998	16,343
Depreciation
Amortisation
Non-Cash Items	6,921	4,170	9,126	10,016	-3,140
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	974	-10,949	-19,147	-17,365	-15,987
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	11,190	1,472	1,788	-1,328	4,914
Capital Expenditures	-24,119	-4,035	-2,931	-5,474	-75,887
Purchase of Fixed Assets
Other Investing Cash Flow Items	14,693	7,154	9,362	22,660	500
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities	-9,426	3,118	6,431	17,186	-75,386
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-11,460	-3,846	-3,728	-5,093	57,198
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-9,978	881	4,569	10,772	-13,147